PMS1 (formerly known as PMSL1) encodes a protein belonging to the DNA mismatch repair mutL/hexB family, suggesting its involvement in DNA mismatch repair. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there is no disease associated with PMS1 in OMIM, although there was an early assertion of association with Lynch syndrome. Thus, it was curated for that disorder.
Summary of Genetic Evidence (Case Level): 0 point Nicolaides et al., 1994, first reported a frameshift germline variant in PMS1 associated with autosomal dominant hereditary non-polyposis colorectal cancer/Lynch syndrome (PMID: 8072530). However, conflicting findings were subsequently noted in another study (Liu et al., 2001, PMID:11691795), where the proband and her nephew with Lynch syndrome reported in PMID: 8072530, in fact, had a large deletion in MSH2 but not PMS1. Liu et al. also failed to detect pathogenic germline mutations in PMS1 from 84 families with Lynch syndrome. Another study also found no germline variants in PMS1 within 34 Lynch syndrome families (PMID: 8574961).
Summary of Experimental Evidence: 0.5 point While a study highlighted the association of PMS1 with hMLH1 as a heterodimer (PMID: 10748105), Prolla et al. (PMID:9500552) generated mice deficient for the murine homologues of the human gene PMS1 and showed that the mice did not develop tumors, and mouse embryonic fibroblast cells deficient for PMS1 showed no defeat in dinucleotide repeats and there was no significant difference of microsatellite instability in the mucosa of PMS-deficient mice compared to wildtypes.
Overall Summary: Considering the lack of substantial association in both genetic and experimental studies, there is convincing evidence refuting the gene-disease relationship between PMS1 and autosomal dominant Lynch syndrome. This gene-disease pair was originally evaluated as disputed on 5/22/2017 by Colon Cancer GCEP. This re-curation was approved by the ClinGen Hereditary Cancer GCEP on 8/25/2023 (SOP Version 9).
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.